Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -89,049 | -42,410 | -108,995 | -81,144 | -48,411 |
| Depreciation Amortization | 586 | 295 | 1,145 | 846 | 560 |
| Accounts payable and accrued liabilities | 5,846 | 1,289 | -153 | 1,973 | 3,921 |
| Other Working Capital | 117 | -4,654 | -5,371 | 1,701 | -2,330 |
| Other Operating Activity | 1,197 | 4,602 | 20,284 | 10,256 | 4,058 |
| Operating Cash Flow | $-81,303 | $-40,878 | $-93,090 | $-66,368 | $-42,202 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -24 | -738 | -488 | -380 |
| Purchase Sale Intangibles | -3,000 | -3,000 | N/A | N/A | N/A |
| Other Investing Activity | -3,000 | -3,000 | 134 | 131 | 71 |
| Investing Cash Flow | $-3,023 | $-3,024 | $-604 | $-357 | $-309 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 49,853 | 49,853 | N/A |
| Debt Repayment | N/A | N/A | -40,612 | -40,612 | N/A |
| Common Stock Issued | 217,272 | 692 | 265,685 | 216,072 | 216,245 |
| Other Financing Activity | 94 | 19 | -337 | -280 | -9 |
| Financing Cash Flow | $217,366 | $711 | $274,589 | $225,033 | $216,236 |
| Beginning Cash Position | 322,531 | 322,531 | 141,636 | 141,636 | 141,636 |
| End Cash Position | 455,571 | 279,340 | 322,531 | 299,944 | 315,361 |
| Net Cash Flow | $133,040 | $-43,191 | $180,895 | $158,308 | $173,725 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,303 | -40,878 | -93,090 | -66,368 | -42,202 |
| Capital Expenditure | -23 | -24 | -738 | -488 | -380 |
| Free Cash Flow | -81,326 | -40,902 | -93,828 | -66,856 | -42,582 |